CranioSacral Therapy for Parkinson's Disease

Recruiting in Palo Alto (17 mi)

Overseen byAl Raza, CST

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Zia, Al Raza

No Placebo Group

Trial Summary

What is the purpose of this trial?

We are studying \& researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.

Research Team

Al Raza, CST

Principal Investigator

IBR, Inc.

Eligibility Criteria

This trial is for individuals who have been diagnosed with Parkinson's Disease. It aims to include those specifically suffering from this condition and excludes anyone who does not have Parkinson's Disease.

Inclusion Criteria

I have been diagnosed with Parkinson's Disease.

Exclusion Criteria

I do not have Parkinson's Disease.

Treatment Details

Interventions

Biweekly Intervention (Behavioural Intervention)

Trial OverviewThe study is testing the effects of CranioSacral Integrative Therapy on patients with Parkinson's Disease over a period of 3 months, involving biweekly therapy sessions lasting 90 minutes each.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: biweekly interventionExperimental Treatment1 Intervention

biweekly intervention